Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 1;134(7):802-9.
doi: 10.1001/jamaophthalmol.2016.1284.

Visual Impairment and Blindness in Adults in the United States: Demographic and Geographic Variations From 2015 to 2050

Affiliations

Visual Impairment and Blindness in Adults in the United States: Demographic and Geographic Variations From 2015 to 2050

Rohit Varma et al. JAMA Ophthalmol. .

Abstract

Importance: The number of individuals with visual impairment (VI) and blindness is increasing in the United States and around the globe as a result of shifting demographics and aging populations. Tracking the number and characteristics of individuals with VI and blindness is especially important given the negative effect of these conditions on physical and mental health.

Objectives: To determine the demographic and geographic variations in VI and blindness in adults in the US population in 2015 and to estimate the projected prevalence through 2050.

Design, setting, and participants: In this population-based, cross-sectional study, data were pooled from adults 40 years and older from 6 major population-based studies on VI and blindness in the United States. Prevalence of VI and blindness were reported by age, sex, race/ethnicity, and per capita prevalence by state using the US Census projections (January 1, 2015, through December 31, 2050).

Main outcomes and measures: Prevalence of VI and blindness.

Results: In 2015, a total of 1.02 million people were blind, and approximately 3.22 million people in the United States had VI (best-corrected visual acuity in the better-seeing eye), whereas up to 8.2 million people had VI due to uncorrected refractive error. By 2050, the numbers of these conditions are projected to double to approximately 2.01 million people with blindness, 6.95 million people with VI, and 16.4 million with VI due to uncorrected refractive error. The highest numbers of these conditions in 2015 were among non-Hispanic white individuals (2.28 million), women (1.84 million), and older adults (1.61 million), and these groups will remain the most affected through 2050. However, African American individuals experience the highest prevalence of visual impairment and blindness. By 2050, the highest prevalence of VI among minorities will shift from African American individuals (15.2% in 2015 to 16.3% in 2050) to Hispanic individuals (9.9% in 2015 to 20.3% in 2050). From 2015 to 2050, the states projected to have the highest per capita prevalence of VI are Florida (2.56% in 2015 to 3.98% in 2050) and Hawaii (2.35% in 2015 and 3.93% in 2050), and the states projected to have the highest projected per capita prevalence of blindness are Mississippi (0.83% in 2015 to 1.25% in 2050) and Louisiana (0.79% in 2015 to 1.20% in 2050).

Conclusions and relevance: These data suggest that vision screening for refractive error and early eye disease may reduce or prevent a high proportion of individuals from experiencing unnecessary vision loss and blindness, decrease associated costs to the US economy for medical services and lost productivity, and contribute to better quality of life. Targeted education and screening programs for non-Hispanic white women and minorities should become increasingly important because of the projected growth of these populations and their relative contribution to the overall numbers of these conditions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimated numbers of persons with visual impairment in the United States by race/ethnicity all persons and year
Figure 2
Figure 2
Estimated number of persons with blindness in the United States by race/ethnicity (all persons) and year
Figure 3
Figure 3
Per capita prevalence of visual impairment in the United States in 2015
Figure 4
Figure 4
Per capita prevalence of visual impairment in the United States in 2050

References

    1. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Archives of ophthalmology. 2004 Apr;122(4):477–485. - PubMed
    1. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA : the journal of the American Medical Association. 2003 Oct 15;290(15):2057–2060. - PubMed
    1. Bourne R, Price H, Stevens G, Group GBDVLE Global burden of visual impairment and blindness. Archives of ophthalmology. 2012 May 1;130(5):645–647. - PubMed
    1. Stevens GA, White RA, Flaxman SR, et al. Global Prevalence of Vision Impairment and Blindness: Magnitude and Temporal Trends, 1990-2010. Ophthalmology. 2013 Jul 10; - PubMed
    1. Engelgau MM, Narayan KM, Saaddine JB, Vinicor F. Addressing the burden of diabetes in the 21st century: better care and primary prevention. J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S88–91. - PubMed

MeSH terms